Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis
出版年份 2011 全文链接
标题
Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 33, Issue 10, Pages 1087-1103
出版商
Wiley
发表日期
2011-03-14
DOI
10.1111/j.1365-2036.2011.04627.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Etiology, Management, and Outcome of the Budd-Chiari Syndrome
- (2013) Sarwa Darwish Murad ANNALS OF INTERNAL MEDICINE
- JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis: authors’ reply
- (2011) R. H. Westbrook et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis
- (2011) X. Qi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis
- (2010) Niamh McCarthy et al. ACTA HAEMATOLOGICA
- The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis
- (2010) D. W. ORR et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- JAK2Mutations Across a Spectrum of Venous Thrombosis Cases: Table 1
- (2010) Shrimati Shetty et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Splanchnic vein thrombosis: clinical presentation, risk factors and treatment
- (2010) Valerio De Stefano et al. Internal and Emergency Medicine
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
- (2009) F. Dentali et al. BLOOD
- Occurrence of the JAK2 V617F mutation in the Budd–Chiari syndrome
- (2009) Donatella Colaizzo et al. BLOOD COAGULATION & FIBRINOLYSIS
- JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis
- (2009) Sandra Guerra Xavier et al. DIGESTIVE DISEASES AND SCIENCES
- Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis
- (2009) Donatella Colaizzo et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study
- (2009) Aurelie Plessier et al. HEPATOLOGY
- Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development
- (2009) Maria Assunta Zocco et al. JOURNAL OF HEPATOLOGY
- ClinicalJAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations
- (2008) Gregory A. Abel et al. AMERICAN JOURNAL OF HEMATOLOGY
- JAK2V617F: better diagnostic tool than marrow?
- (2008) H. C. Kwaan BLOOD
- The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
- (2008) J.-J. Kiladjian et al. BLOOD
- JAK2V617F Mutation in Patients with Portal Vein Thrombosis
- (2008) Yusuf Bayraktar et al. DIGESTIVE DISEASES AND SCIENCES
- Primary thrombophilia in México VII: the V617F mutation ofJAK2is not a frequent cause of thrombosis
- (2008) Javier Garcés-Eisele et al. Hematology
- Vascular disorders of the liver
- (2008) Laurie D. DeLeve et al. HEPATOLOGY
- JAK2 V617F mutation is not involved in thromboembolism in IBD
- (2008) Ouafae Karimi et al. INFLAMMATORY BOWEL DISEASES
- TheJAK2V617Ftyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis
- (2007) C. GOULDING et al. International Journal of Laboratory Hematology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started